These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. Ondansetron: a review of its use as an antiemetic in children. Culy CR; Bhana N; Plosker GL Paediatr Drugs; 2001; 3(6):441-79. PubMed ID: 11437189 [TBL] [Abstract][Full Text] [Related]
7. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Smyth AR; Barbato A; Beydon N; Bisgaard H; de Boeck K; Brand P; Bush A; Fauroux B; de Jongste J; Korppi M; O'Callaghan C; Pijnenburg M; Ratjen F; Southern K; Spencer D; Thomson A; Vyas H; Warris A; Merkus PJ Eur Respir J; 2010 Feb; 35(2):247-65. PubMed ID: 19840958 [TBL] [Abstract][Full Text] [Related]
8. [Peculiarities of theophylline therapy in childhood]. Sollich V; Schuster R; Thal W; Köhler E; Walther H Z Erkr Atmungsorgane; 1988; 170(2):100-7. PubMed ID: 3041688 [TBL] [Abstract][Full Text] [Related]
9. [Peculiarities of drug therapy in childhood]. Reinhardt D; Kusenbach G Monatsschr Kinderheilkd; 1986 Nov; 134(11):772-8. PubMed ID: 3807917 [TBL] [Abstract][Full Text] [Related]
10. Pediatric drug formulations: a review of challenges and progress. Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739 [TBL] [Abstract][Full Text] [Related]
11. Extemporaneous drug formulations. Nahata MC; Allen LV Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799 [TBL] [Abstract][Full Text] [Related]
13. Evaluation and simplification of the World Health Organization clinical case definition for paediatric AIDS. Lepage P; van de Perre P; Dabis F; Commenges D; Orbinski J; Hitimana DG; Bazubagira A; van Goethem C; Allen S; Butzler JP AIDS; 1989 Apr; 3(4):221-5. PubMed ID: 2500955 [TBL] [Abstract][Full Text] [Related]
14. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants]. Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737 [TBL] [Abstract][Full Text] [Related]
15. Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects. van Riet-Nales DA; Schobben AF; Vromans H; Egberts TC; Rademaker CM Arch Dis Child; 2016 Jul; 101(7):662-9. PubMed ID: 26979250 [TBL] [Abstract][Full Text] [Related]
16. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic approaches to cystic fibrosis: memorandum from a joint WHO/ICF(M)A meeting. Bull World Health Organ; 1994; 72(3):341-52. PubMed ID: 7520369 [TBL] [Abstract][Full Text] [Related]